+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID06649955

Evaluation of the MyoRegulator Device for Treating ALS Motor Neuron Excitability in Adults with Amyotrophic Lateral Sclerosis

Led by PathMaker Neurosystems Inc. · Updated on 2026-09-10

15

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the MyoRegulator4 device as a treatment for individuals with amyotrophic lateral sclerosis ALS, a progressive neurodegenerative disease affecting motor neurons and leading to motor and cognitive impairments. This single-arm, non-significant risk study aims to assess the feasibility, safety, and preliminary effectiveness of the device in a larger group of ALS patients following an earlier feasibility study. The study focuses on motor neuron hyperexcitability, which the device targets through neuromodulation. Participants will receive non-invasive multi-site direct current stimulation multi-site DCS using the MyoRegulator4 device for 4 weeks, with treatments administered three times per week. After the treatment phase, participants will have follow-up visits at 1 week, 1 month, 3 months, and optionally at 6 months to monitor outcomes. This study will gather additional evidence on clinical safety and potential effectiveness prior to a larger sham-controlled trial. Throughout the study, participants will undergo various assessments including ALS functional rating scales, disability scales, questionnaires, strength tests, nerve conduction studies, cortical motor neuron excitability measurements via transcranial magnetic stimulation, and lung function tests. Feasibility will be measured by participant enrollment rates, treatment delivery ease, tolerability, and compliance. Safety will be monitored by recording adverse events during treatment and follow-up visits up to 6 months post-treatment.

CONDITIONS

Brief Title

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Research Team

S

Seward Rutkove (Clinical Site PI), M.D.

N

Nader Yaghoubi (Study PI), M.D., Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here